红斑毛细血管扩张型玫瑰痤疮的治疗研究进展

王 伯淳, 罗 紫瑾, 杨 洁
华北理工大学附属医院皮肤科

摘要

玫瑰痤疮(rosacea)是一种好发于面中部的慢性复发性炎症性疾病,病因复杂,治疗困难｡玫瑰痤疮的类型有很多,其中最常见的是红斑毛细血管扩张型玫瑰痤疮(ETR),这种疾病会导致红斑和毛细血管扩张,给患者带来严重的生理和心理影响｡目前针对ETR的治疗包括:口服药､外用药治疗､光电治疗以及肉毒素治疗等｡另外,生活习惯对ETR同样至关重要,本文将结合国内外最新研究对ETR的治疗进展进行综述｡

关键词

玫瑰痤疮;红斑毛细血管扩张型;治疗

参考

[1]宋晓婷,刘擘,陈玉迪,赵作涛.玫瑰痤疮的病理生理发病机制研究进展.中华皮肤科杂志.2022.55(5):446-449.[2]PhD.[Rosacea-dermocosmeticmanagement:skin-careandcorrectivemake-up].ANNALESDEDERMATOLOGIEETDEVENEREOLOGIE.2014.141Suppl2:S179-83.[3]SearleT,AliFR,CarolidesS,Al-NiaimiF.RosaceaandDiet:WhatisNewin2021.JClinAesthetDermatol.2021.14(12):49-54.[4]AnzengruberF,CzernielewskiJ,ConradC,etal.SwissS1guidelineforthetreatmentofrosacea.JEurAcadDermatolVenereol.2017.31(11):1775-1791.[5]GaramiA,ShimanskyYP,RumbusZ,etal.Hyperthermiainducedbytransientreceptorpotentialvanilloid-1(TRPV1)antagonistsinhumanclinicaltrials:Insightsfrommathematicalmodelingandmeta-analysis.PharmacolTher.2020.208:107474.[6]LaytonAM,SchallerM,HomeyB,etal.Brimonidinegel0.33%rapidlyimprovespatient-reportedoutcomesbycontrollingfacialerythemaofrosacea:arandomized,double-blind,vehicle-controlledstudy.JEurAcadDermatolVenereol.2015.29(12):2405-10.[7]赵静,邓永琼,熊霞.盐酸羟甲唑啉治疗玫瑰痤疮相关持久性面部红斑的临床疗效与安全性研究.中国现代医学杂志.2022.32(17):93-96.[8]AdityanB,KumariR,ThappaDM.Scoringsystemsinacnevulgaris.IndianJDermatolVenereolLeprol.2009.75(3):323-6.[9]XuL,YaoB,XuT,HuangH.AssessmentoftheEfficacyandSafetyof30%SupramolecularSalicylicAcidPeelingforPapulopustularRosaceaTreatment.IndianJDermatol.2022.67(5):625.[10]LiY,XieH,DengZ,etal.Tranexamicacidamelioratesrosaceasymptomsthroughregulatingimmuneresponseandangiogenesis.IntImmunopharmacol.2019.67:326-334.[11]JakharD,KaurI,MisriR.Topical10%tranexamicacidforerythematotelangiectaticsteroid-inducedrosacea.JAmAcadDermatol.2022.86(1):e1-e2.[12]DelRossoJQ,WebsterG,WeissJS,BhatiaND,GoldLS,KircikL.NonantibioticPropertiesofTetracyclinesinRosaceaandTheirClinicalImplications.JClinAesthetDermatol.2021.14(8):14-21.[13]DelRossoJQ,ThiboutotD,GalloR,etal.ConsensusrecommendationsfromtheAmericanAcne&RosaceaSocietyonthemanagementofrosacea,part3:astatusreportonsystemictherapies.Cutis.2014.93(1):18-28.[14]LiJ,YuanX,TangY,etal.Hydroxychloroquineisanoveltherapeuticapproachforrosacea.IntImmunopharmacol.2020.79:106178.[15]PietschkeK,SchallerM.Long-termmanagementofdistinctfacialflushingandpersistenterythemaofrosaceabytreatmentwithcarvedilol.JDermatologTreat.2018.29(3):310-313.[16]SeoBH,KimDH,SuhHS,ChoiYS.Facialflushinganderythemaofrosaceaimprovedbycarvedilol.DermatolTher.2020.33(6):e14520.[17]vanZuurenEJ,FedorowiczZ,TanJ,etal.Interventionsforrosaceabasedonthephenotypeapproach:anupdatedsystematicreviewincludingGRADEassessments.BrJDermatol.2019.181(1):65-79.[18]TsunodaK,AkasakaK,AkasakaT,AmanoH.Successfultreatmentoferythematotelangiectaticrosaceawithintensepulsedlight:Reportof13cases.JDermatol.2018.45(9):1113-1116.[19]BaekJO,HurH,RyuHR,etal.Treatmentoferythematotelangiectaticrosaceawiththefractionationofhigh-fluence,long-pulsed595-nmpulseddyelaser.JCosmetDermatol.2017.16(1):12-14.[20]ParkS,LeeJH,KangE,etal.Arandomizedsplit-facecomparativestudyoflong-pulsedalexandritepluslow-fluenceNd:YAGlaserversuspulsed-dyelaserinthetreatmentofrosacea.LasersSurgMed.2022.54(9):1217-1225.[21]PiccoloD,ZalaudekI,GenovesiC,etal.Long-pulsedNd:YAGlaserusingan"inmotion"settingtotreattelangiectaticrosacea.AnnDermatolVenereol.2023.150(2):121-122.[22]KwonWJ,ParkBW,ChoEB,ParkEJ,KimKH,KimKJ.Comparisonofefficacybetweenlong-pulsedNd:YAGlaserandpulseddyelasertotreatrosacea-associatednasaltelangiectasia.JCosmetLaserTher.2018.20(5):260-264.[23]ChoiJE,WerbelT,WangZ,WuCC,YakshTL,DiNardoA.Botulinumtoxinblocksmastcellsandpreventsrosacealikeinflammation.JDermatolSci.2019.93(1):58-64.[24]中华医学会皮肤性病学分会玫瑰痤疮研究中心,中国医师协会皮肤科医师分会玫瑰痤疮专业组.A型肉毒毒素皮内注射治疗玫瑰痤疮持久性红斑及潮红专家共识.中华皮肤科杂志.2023.56(1):16-21.[25]熊庆,曾静,杨沁馨,卫雪.A型肉毒毒素联合强脉冲光治疗玫瑰痤疮的临床观察.中国美容医学.2022.31(10):51-54.[26]AmirAliA,VenderR,VenderR.TheRoleofIL-17inPapulopustularRosaceaandFutureDirections.JCutanMedSurg.2019.23(6):635-641.